Caricamento...
Silymarin for the Prevention of Contrast-Induced Nephropathy: A Placebo-Controlled Clinical Trial
BACKGROUND: Silymarin is a flavonoid complex with nephro-protective properties. We evaluated the efficacy of silymarin in the prevention of contrast-induced nephropathy (CIN). METHODS: This placebo-controlled clinical trial was conducted on 143 patients with chronic stable angina referring for elect...
Salvato in:
| Pubblicato in: | Int J Prev Med |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Medknow Publications & Media Pvt Ltd
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4755255/ https://ncbi.nlm.nih.gov/pubmed/26941924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2008-7802.174762 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|